Jump Financial, LLC Alector, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$5.69 - $8.08 $90,613 - $128,674	15,925 New	15,925 $95,000
Q1 2022 May 12, 2022	SELL	$13.02 - $20.78 $1.06 Million - $1.7 Million	-81,600 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$19.35 - $25.54 $775,935 - $1.02 Million	40,100 Added 96.63%	81,600 $1.69 Million
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $898,474 - $1.64 Million	41,500 New	41,500 $947,000
Q4 2020 Feb 12, 2021	SELL	$9.4 - $16.7 $288,580 - $512,690	-30,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$10.54 - $24.96 $323,578 - $766,272	30,700 New	30,700 $323,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.